Reverse-phase protein microarray highlights HER2 signaling activation in immunohistochemistry/FISH/HER2-negative breast cancers

Author： Tessitore Alessandra Zazzeroni Francesca Alesse Edoardo

Publisher： Informa Healthcare

ISSN： 1478-9450

Source： Expert Review of Proteomics, Vol.10, Iss.3, 2013-06, pp. : 223-226

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HER2 as a target for breast cancer therapy

By Tagliabue Elda Balsari Andrea Campiglio Manuela Pupa Serenella M

Expert Opinion on Biological Therapy, Vol. 10, Iss. 5, 2010-05 ,pp. : 711-724

Informa Healthcare

Access to resources Recommend Favorite

p66 Shc Isoform Down-Regulated and Not Required for HER-2/neu Signaling Pathway in Human Breast Cancer Cell Lines with HER-2/neu Overexpression

By Xie Y. Hung M.C.

Biochemical and Biophysical Research Communications, Vol. 221, Iss. 1, 1996-04 ,pp. : 140-145

Elsevier

Access to resources Recommend Favorite

Pertuzumab: evolving therapeutic strategies in the management of HER2-overexpressing breast cancer

By O'Sullivan Ciara C Swain Sandra M

Expert Opinion on Biological Therapy, Vol. 13, Iss. 5, 2013-05 ,pp. : 779-790

Informa Healthcare

Access to resources Recommend Favorite

Her signaling in pancreatic cancer

By Burtness Barbara

Expert Opinion on Biological Therapy, Vol. 7, Iss. 6, 2007-06 ,pp. : 823-829

Informa Healthcare

Access to resources Recommend Favorite

ErbB Receptor Activation, Cell Morphology Changes, and Apoptosis Induced by Anti-Her2 Monoclonal Antibodies

By Kita Y. Tseng J. Horan T. Wen J. Philo J. Chang D. Ratzkin B. Pacifici R. Brankow D. Hu S. Luo Y. Wen D. Arakawa T. Nicolson M.

Biochemical and Biophysical Research Communications, Vol. 226, Iss. 1, 1996-09 ,pp. : 59-69

Elsevier

Access to resources Recommend Favorite